Clinical Trials: NYU 05-40 PBMTC ONC-032P:High Dose Temozolomide,Thiotepa and Carboplatin With Autologous Stem Cell Rescue (ASCR) Followed by Continuation Therapy With 13-Cis-Retinoic Acid in Patients With Recurrent/Refractory Malignant Brain Tumors

Sponsor and Collaborators

New York University School of Medicine

Children’s Hospitals and Clinics of Minnesota

Schneider Children’s Hospital

Contact

Sharon L Gardner, MD, 212-263-8400, [email protected]

Monique duPlessis, 212-263-9929, [email protected]

Principal Investigator

Sharon L Gardner, MD, New York University Medical Center

ClinicalTrials.gov Identifier